Skip to content
Rheiazymes  logo β€” 🧬🦠 ENZYMES TURNING WASTE INTO VALUE

Rheiazymes

🧬🦠 ENZYMES TURNING WASTE INTO VALUE

Founded 2022 Switzerland Switzerland 2 employees Grant Biotechnology

General Information

Company Name Rheiazymes
Founded Year 2022
Location Switzerland Switzerland
Employees 2
Industries Biotechnology
Funding Stage Grant
Social

BounceWatch is an independent company data service, not affiliated with Rheiazymes . To contact Rheiazymes , visit rheiazymes.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Rheiazymes compare?

A PDF of Rheiazymes and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Rheiazymes soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Rheiazymes

Rheiazymes is a biotechnology startup based in Switzerland, founded in 2022. The company's slogan, "🧬🦠 ENZYMES TURNING WASTE INTO VALUE," reflects its core mission of utilizing molecular recycling to transform non-recyclable or hard-to-recycle products, ranging from textiles to electronics and compound packaging, into valuable raw materials. This innovative approach not only enables the upcycling of waste products but also facilitates the transition of entire value chains towards a circular economy model. As of now, there is no publicly available information on Rheiazymes's last investment or the participating investors. However, the company's focus on leveraging enzymes for sustainable waste management presents an intriguing prospect for potential venture capital involvement. In an era characterized by a growing emphasis on environmental sustainability and resource efficiency, Rheiazymes' innovative biotechnological solutions hold significant potential for disrupting traditional waste management practices and advancing the transition towards a more circular and environmentally conscious economy.

Business keywords: Molecular Recycling, Circular Economy, Biotech, Plastics Recycling, Textile Industry, Raw Material Recovery, Polymer Recovery, Sustainable Fashion, Waste-to-Value, Nylon-Elastane Blends, Circular Supply Chain, Material Innovation

No funding data available for Rheiazymes yet.

Rheiazymes Alternatives & Competitors

View All Alternatives
Rheiazymes vs

Ready to change the world? Let’s change clothes.

Series B
49 employees
Biotechnology
Rheiazymes vs
CARBIOS
CARBIOS France

Biotechnology powering plastic and textile circularity

Grant
112 employees
Biotechnology, Sustainability
Rheiazymes vs
Recircle
Recircle United Kingdom

We are a recycling and biotechnology company, working passionately together to preserve our world fo...

38 employees
Biotechnology, Manufacturing

FAQ About Rheiazymes

🧬🦠 ENZYMES TURNING WASTE INTO VALUE
Rheiazymes was founded in 2022.
Rheiazymes is headquartered in Switzerland.
Rheiazymes operates in Biotechnology. Its work centres on Molecular Recycling, Circular Economy, Biotech and Plastics Recycling.
Rheiazymes has approximately 2 employees.
Top alternatives and competitors to Rheiazymes include Infinited Fiber Company, CARBIOS, Recircle, mobius, Nova Molecular Technologies, Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Rheiazymes and Infinited Fiber Company are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Rheiazymes , https://bouncewatch.com/company/rheiazymes, updated 29 November 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout